NexusPharma, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for NexusPharma, Inc..The latest application filed is for "c-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition".
- NexusPharma, Inc. - Philadelphia PA
- NexusPharma, Inc. - Langhome PA US
- NexusPharma, Inc. - Langhorne PA
| Patent | Date |
|---|---|
| C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition Grant 10,328,050 - Astsaturov , et al. | 2019-06-25 |
| C-MYC As A Biomarker For Tumor Sensitivity To Treatment With RNA Polymerase II Inhibition App 20180263955 - Astsaturov; Igor ; et al. | 2018-09-20 |
| Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors Grant 9,993,458 - Astsaturov , et al. June 12, 2 | 2018-06-12 |
| Tetrahydro-isoquinolines Grant 8,367,699 - Weber , et al. February 5, 2 | 2013-02-05 |
| Tetrahydro-isoquinolin-1-ones for the treatment of cancer Grant 8,163,744 - Weber , et al. April 24, 2 | 2012-04-24 |
| NCAGE Code | 47HG6 | NEXUSPHARMA INC |
| CAGE Code | 47HG6 | NEXUSPHARMA INC |
| DUNS | 171066686 | NEXUSPHARMA INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 